These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 24985921

  • 21. [Large vessel vasculitis as cause of fever of unknown origin (FUO) or systemic inflammation. Diagnosis using 18-F-fluor-2-deoxy-D-glucose positron emission tomography ((18)F-FDG-PET)].
    Amberger CC, Dittmann H, Overkamp D, Brechtel K, Bares R, Kötter I.
    Z Rheumatol; 2005 Feb; 64(1):32-9. PubMed ID: 15756498
    [Abstract] [Full Text] [Related]

  • 22. FDG-PET in patients with fever of unknown origin: the importance of diagnosing large vessel vasculitis.
    Meller J, Sahlmann CO, Gürocak O, Liersch T, Meller B.
    Q J Nucl Med Mol Imaging; 2009 Feb; 53(1):51-63. PubMed ID: 19182728
    [Abstract] [Full Text] [Related]

  • 23. Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study.
    Martin C, Castaigne C, Tondeur M, Flamen P, De Wit S.
    HIV Med; 2013 Sep; 14(8):455-62. PubMed ID: 23517190
    [Abstract] [Full Text] [Related]

  • 24. Contribution of (18)F-FDG PET in the diagnostic assessment of fever of unknown origin (FUO): a stratification-based meta-analysis.
    Besson FL, Chaumet-Riffaud P, Playe M, Noel N, Lambotte O, Goujard C, Prigent A, Durand E.
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1887-95. PubMed ID: 27037917
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Superiority of 18F-FDG PET compared to 111In-labelled leucocyte scintigraphy in the evaluation of fever of unknown origin.
    Seshadri N, Sonoda LI, Lever AM, Balan K.
    J Infect; 2012 Jul; 65(1):71-9. PubMed ID: 22369860
    [Abstract] [Full Text] [Related]

  • 28. Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience.
    Federici L, Blondet C, Imperiale A, Sibilia J, Pasquali JL, Pflumio F, Goichot B, Blaison G, Weber JC, Christmann D, Constantinesco A, Andrès E.
    Int J Clin Pract; 2010 Jan; 64(1):55-60. PubMed ID: 18479364
    [Abstract] [Full Text] [Related]

  • 29. Role of integrated PET/CT with [¹⁸F]-FDG in the management of patients with fever of unknown origin: a single-centre experience.
    Pelosi E, Skanjeti A, Penna D, Arena V.
    Radiol Med; 2011 Aug; 116(5):809-20. PubMed ID: 21424320
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Value of FDG PET in patients with fever of unknown origin.
    Lorenzen J, Buchert R, Bohuslavizki KH.
    Nucl Med Commun; 2001 Jul; 22(7):779-83. PubMed ID: 11453051
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin.
    Bleeker-Rovers CP, Vos FJ, Mudde AH, Dofferhoff ASM, de Geus-Oei LF, Rijnders AJ, Krabbe PFM, Corstens FHM, van der Meer JWM, Oyen WJG.
    Eur J Nucl Med Mol Imaging; 2007 May; 34(5):694-703. PubMed ID: 17171357
    [Abstract] [Full Text] [Related]

  • 34. Relationships between Causes of Fever of Unknown Origin and Inflammatory Markers: A Multicenter Collaborative Retrospective Study.
    Naito T, Torikai K, Mizooka M, Mitsumoto F, Kanazawa K, Ohno S, Morita H, Ukimura A, Mishima N, Otsuka F, Ohyama Y, Nara N, Murakami K, Mashiba K, Akazawa K, Yamamoto K, Tanei M, Yamanouchi M, Senda S, Tazuma S, Hayashi J.
    Intern Med; 2015 May; 54(16):1989-94. PubMed ID: 26278289
    [Abstract] [Full Text] [Related]

  • 35. Fever of unknown origin: discrimination between infectious and non-infectious causes.
    Efstathiou SP, Pefanis AV, Tsiakou AG, Skeva II, Tsioulos DI, Achimastos AD, Mountokalakis TD.
    Eur J Intern Med; 2010 Apr; 21(2):137-43. PubMed ID: 20206887
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [A search for the focus in patients with fever of unknown origin: is positron-emission tomography with F-18-fluorodeoxyglucose helpful?].
    Lorenzen J, Buchert R, Bleckmann C, Münchow N, Bohuslavizki KH.
    Rofo; 1999 Jul; 171(1):49-53. PubMed ID: 10464505
    [Abstract] [Full Text] [Related]

  • 38. [Approach to fever of unknown origin: the role of positron-emission tomography].
    Poncini G, Nendaz M.
    Rev Med Suisse; 2010 Feb 03; 6(234):249-53. PubMed ID: 20334084
    [Abstract] [Full Text] [Related]

  • 39. [Nuclear medicine diagnosis of patients with fever of unknown origin (FUO)].
    Meller J, Becker W.
    Nuklearmedizin; 2001 Jun 03; 40(3):59-70. PubMed ID: 11475074
    [Abstract] [Full Text] [Related]

  • 40. Clinical value of dual-phase 18F-FDG SPECT with serum procalcitonin for identification of etiology in tumor patients with fever of unknown origin.
    Zhang Q, Shan C, Wu P, Huang XE.
    Asian Pac J Cancer Prev; 2014 Jun 03; 15(2):683-6. PubMed ID: 24568478
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.